The membrane molecule RCAS1 induces immune cell apoptosis via the RCAS1-RCAS1R pathway

International Journal of Molecular Medicine

Volumn 31, Issue 6, 2013, Pages 1319-1326

  Zhang, Yuanyuan ^a   Zhu, Jie ^b   Hong, Xuejun ^c   Zhou, Yunlian ^a   Ren, Keming ^a   Shu, Xiaoli ^a   Wang, Qingqing ^d  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG HOSPITAL   (China)

^c Xuancheng Blood Center   (China)

^d ZHEJIANG UNIVERSITY   (China)

Author keywords

Apoptosis; Immune cell; Pathway; RCAS1 RCAS1R; Receptor binding cancer antigen expressed on SiSo cells

Indexed keywords

ADENOVIRUS VECTOR; GLYCOGEN SYNTHASE KINASE 3BETA; PHYTOHEMAGGLUTININ; RECEPTOR; TUMOR ANTIGEN; TUMOR ASSOCIATED ANTIGEN RECEPTOR BINDING CANCER ANTIGEN EXPRESSED ON SISO CELLS; TUMOR ASSOCIATED ANTIGEN RECEPTOR BINDING CANCER ANTIGEN EXPRESSED ON SISO CELLS RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; LEUKEMIA CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL;

ADENOVIRIDAE; ANTIGENS, NEOPLASM; APOPTOSIS; BREAST NEOPLASMS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GENETIC VECTORS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; JURKAT CELLS; K562 CELLS; PHOSPHORYLATION; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 84876372488     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1326     Document Type: Article

References (22)

1. Tsuchiya F, Ikeda K, Tsutsumi O, et al: Molecular cloning and characterization of mouse EBAG9, homolog of a human cancer associated surface antigen: expression and regulation by estrogen. Biochem Biophys Res Commun 284: 2-10, 2001. (Pubitemid 32924300)
2. Suzuki T, Inoue S, Kawabata W, et al: EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions. Br J Cancer 85: 1731-1737, 2001. (Pubitemid 34081520)
3. Akahira JI, Aoki M, Suzuki T, et al: Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer. Br J Cancer 90: 2197-2202, 2004. (Pubitemid 38869730)
4. Takahashi S, Urano T, Tsuchiya F, et al: EBAG9/RCAS1 expression and its prognostic significance in prostatic cancer. Int J Cancer 106: 310-315, 2003. (Pubitemid 36870389)
5. Aoki T, Inoue S, Imamura H, et al: EBAG9/RCAS1 expression in hepatocellular carcinoma: correlation with tumour dedifferentiation and proliferation. Eur J Cancer 39: 1552-1561, 2003. (Pubitemid 36833221)
6. Nakashima M, Sonoda K and Watanabe T: Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 5: 938-942, 1999. (Pubitemid 29372422)
7. Matsushima T, Nakashima M, Oshima K, et al: Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells. Blood 98: 313-321, 2001.
8. Sonoda K, Miyamoto S, Yamazaki A, Kobayashi H, Nakashima M, Mekada E and Wake N: Biologic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a pivotal regulator of tumor growth through angiogenesis in human uterine cancer. Cancer 110: 1979-1990, 2007. (Pubitemid 350036857)
9. Oshikiri T, Miyamoto M, Morita T, et al: Tumor-associated antigen recognized by the 22-1-1 monoclonal antibody encourages colorectal cancer progression under the scanty CD8+ T cells. Clin Cancer Res 12: 411-416, 2006 (Pubitemid 43166129)
10. Chatterjee M, Mohapatra S, Ionan A, et al: Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res 66: 1181-1190, 2006. (Pubitemid 43165989)
11. Hong XJ, Shen FP and Wang QQ: Construction of recombinant GST-RCAS1 fusion gene and its expression in E. Coli. Zhejiang Da Xue Xue Bao Yi Xue Ban 35: 377-383, 2006 (In Chinese).
12. Hong X, Liu Y, Hu G, et al: EBAG9 inducing hyporesponsiveness of T cells promotes tumor growth and metastasis in 4T1 murine mammary carcinoma. Cancer Sci 100: 961-969, 2009.
13. Reed LJ and Muench HA: A simple method for estimating fifty percent endpoint. Am J Hyg 27 : 493-497, 1938.
14. Engelsberg A, Hermosilla R, Karsten U, Schülein R, Dörken B, and Rehm A: The Golgi protein RCAS1 controls cell surface expression of tumor-associated O-linked glycan antigens. J Biol Chem 278: 22998-23007, 2003. (Pubitemid 36830365)
15. Reimer TA, Anagnostopoulos I, Erdmann B, et al: Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker. BMC Cancer 5: 47, 2005.
16. Embi N, Rylatt DB and Cohen P: Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem 107: 519-527, 1980.
17. Woodgett JR and Cohen P: Multisite phosphorylation of glycogen synthase. Molecular basis for the substrate specificity of glycogen synthase kinase-3 and casein kinase-II (glycogen synthase kinase-5). Biochim Biophys Acta 788: 339-347, 1984.
18. Jope RS and Johnson GV: The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29: 95-102, 2004. (Pubitemid 38186580)
19. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O and Woodgett JR: Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406: 86-90, 2000. (Pubitemid 30460216)
20. Martin M, Rehani K, Jope RS and Michalek SM: Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase Nat Immunol 6: 777-784, 2005. (Pubitemid 43090463)
21. Dutsch-Wicherek M and Wicherek L: The association of RCAS1 serum concentration with the reversibility or irreversibility of the process of immune cytotoxic activity restriction during normal menstrual cycle, cancer relapse, and surgical treatment for various types of squamous cell carcinomas and adenocarcinomas. Am J Reprod Immunol 59: 266-275, 2008. (Pubitemid 351250427)
22. Dutsch-Wicherek M, Tomaszewska R, Lazar A, Wicherek L and Skladzien J: The association between RCAS1 expression in laryngeal and pharyngeal cancer and its healthy stroma with cancer relapse. BMC Cancer 28: 9-35, 2009.